ANIX (Anixa Biosciences) Interest Coverage: N/A (As of Apr. 2026)

Anixa Biosciences  (NAS:ANIX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Anixa Biosciences Interest Coverage Related Terms

The historical data trend for Anixa Biosciences's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Anixa Biosciences Interest Coverage Chart

Anixa Biosciences Annual Data
	Trend	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24	Oct25
Interest Coverage		Get a 7-Day Free Trial					N/A	N/A	N/A	N/A	N/A

Anixa Biosciences Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
Interest Coverage	Get a 7-Day Free Trial															N/A	N/A	N/A	N/A	N/A

ANIX vs PYPD, LONA, SGMO: Interest Coverage Comparison

For the Biotechnology subindustry, Anixa Biosciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anixa Biosciences Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's Interest Coverage falls into.

Anixa Biosciences Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Else if Interest Expense is negative and Operating Income is negative, then

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anixa Biosciences's Interest Coverage for the fiscal year that ended in Oct. 2025 is calculated as

Here, for the fiscal year that ended in Oct. 2025, Anixa Biosciences's Interest Expense was $0.00 Mil. Its Operating Income was $-11.70 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.16 Mil.

Anixa Biosciences's Interest Coverage for the quarter that ended in Apr. 2026 is calculated as

Here, for the three months ended in Apr. 2026, Anixa Biosciences's Interest Expense was $0.00 Mil. Its Operating Income was $-2.65 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Anixa Biosciences Business Description